"Programmable mRNA Therapy for Solid Tumor Treatment Undergoes Testing"

Scientists are planning to test a new cancer treatment using mRNA, which has been successful in Covid-19 vaccines. The treatment, developed by Strand Therapeutics, involves programming mRNA to produce an inflammatory protein called interleukin-12 (IL-12) that triggers the immune system to attack cancer cells. The mRNA is designed to self-destruct if it goes to unintended locations, and initial trials will focus on melanoma and breast cancer. This approach aims to address the challenge of delivering mRNA to specific locations in the body and could potentially revolutionize cancer therapy.